United States Pharmaceutical Supply Chain Review Act

Fact Sheet API

Bill Number

S 1367

Introduced

Apr 26, 2021

Latest Action

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

Sponsor

Cosponsors

Topics

Congressional oversight Genetics Government information and archives Government studies and investigations Health Health technology, devices, supplies Industrial policy and productivity Manufacturing Prescription drugs Retail and wholesale trades U.S. and foreign investments

Full Text

View Full Bill Text

Votes

Summary

United States Pharmaceutical Supply Chain Review Act

This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.

Actions

Apr 26, 2021

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Apr 26, 2021

Introduced in Senate

Amendments

Related Bills